Terms: = Breast cancer AND ETV5, P41161, 2119, ENSG00000244405, ERM AND Prognosis
7 results:
1. Clinicopathological Features and prognosis of Gastrointestinal Metastases From breast Carcinoma: A Clinicopathological Study of 22 Patients.
Wang S; Li W; Li S; Liu X; Zhang L; Hao C; Meng W; Zhao W; Tong Z
Int J Surg Pathol; 2023 Sep; 31(6):1075-1084. PubMed ID: 36803140
[No Abstract] [Full Text] [Related]
2. Survival and prognostic factors in oligometastatic breast cancer.
van Ommen-Nijhof A; Steenbruggen TG; Capel L; Vergouwen M; Vrancken Peeters MT; Wiersma TG; Sonke GS
Breast; 2023 Feb; 67():14-20. PubMed ID: 36549169
[TBL] [Abstract] [Full Text] [Related]
3. Nuclear NHERF1 expression as a prognostic marker in breast cancer.
Paradiso A; Scarpi E; Malfettone A; Addati T; Giotta F; Simone G; Amadori D; Mangia A
Cell Death Dis; 2013 Nov; 4(11):e904. PubMed ID: 24201803
[TBL] [Abstract] [Full Text] [Related]
4. erm/Rho protein expression in ductal breast cancer: a 15 year follow-up.
Halon A; Donizy P; Surowiak P; Matkowski R
Cell Oncol (Dordr); 2013 Jun; 36(3):181-90. PubMed ID: 23420497
[TBL] [Abstract] [Full Text] [Related]
5. Ezrin and BCAR1/p130Cas mediate breast cancer growth as 3-D spheroids.
Konstantinovsky S; Davidson B; Reich R
Clin Exp Metastasis; 2012 Aug; 29(6):527-40. PubMed ID: 22476538
[TBL] [Abstract] [Full Text] [Related]
6. Clinical implications of the influence of Ehm2 on the aggressiveness of breast cancer cells through regulation of matrix metalloproteinase-9 expression.
Yu H; Ye L; Mansel RE; Zhang Y; Jiang WG
Mol Cancer Res; 2010 Nov; 8(11):1501-12. PubMed ID: 21047774
[TBL] [Abstract] [Full Text] [Related]
7. [Transcription factors of the PEA3 group in mammary cancer].
Monté D; Baert JL; Laget MP; Defossez PA; Coutte L; Pelczar H; Angeli I; Dewitte F; Stéhelin D; De Launoit Y
Ann Endocrinol (Paris); 1995; 56(5):547-51. PubMed ID: 8597501
[TBL] [Abstract] [Full Text] [Related]
